Profile
About us
One Pharma is one of the fastest growing manufacturers of Pharmaceutical Finished dosages in Greece. Under the name of Pharmanel , the company was established in 1991 in Athens, originally as a commercial pharmaceutical company.
Today our plant, ISO:9001-2015 and eu-GMP certified, is designed to conform to the principles of Quality, Safety and Environmental protection.
One Pharma has won the trust of more than 50 customers across 15 countries around the globe covering Europe, Canada, Middle-East, Asia and CIS markets. Our product basket offers more than 200 Formulations covering the majority of therapeutic catergories.
The role of our dedicated and talented personnel with their diverse skills, abilities, energy and commitment to work is vital in the overall success of the company.
The average experience of the team is 15 years covering Production, Quality Control, Formulation Development, Quality Management, Supply Chain Management, Project Management and Environmental Safety.
History
1991: Pharmanel SA starts its commercial activities in pharmaceutical business.
1993: Acquisition of Bristol Myers Squibb manufacturing facilities in Greece.
1996: Start of manufacturing activities.
1999: 1st product development.
2003: High growth of portfolio.
2004: Beginning of export activities.
2009: Expansion of the scope of Manufacturing License and facilities.
2012: Split of Pharmanel Pharmaceuticals SA to One Pharma SA
dedicated to manufacturing and Pharmanel Commercial Pharmaceuticals SA
focusing in product promotion and licensing out.
Mission
One Pharma aims to develop onto one of the leading generic companies in Europe. We endeavor to provide high quality innovative products and services and satisfy customer needs.
To accomplish this we constantly enhance our portfolio with innovative products and we amplify our international presence.
Our future
With an outstanding workforce, cutting-edge science, state-of-the-art technology base and knowledge-intensive initiatives, we are working on innovative solutions for tomorrow`s healthcare problems.